Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
2007-7-30
pubmed:abstractText
To investigate whether differences in plasma pharmacokinetic profiles of gefitinib between healthy subjects having normal (N; t(1/2)>20h) and altered (A; t(1/2)<20h) pharmacokinetic (PK) profiles might be explained by inter-individual variability in gastric emptying and/or precipitation/dissolution of gefitinib in the proximal small intestine.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0378-5173
pubmed:author
pubmed:issnType
Print
pubmed:day
16
pubmed:volume
341
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
134-42
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:17482782-Administration, Oral, pubmed-meshheading:17482782-Adult, pubmed-meshheading:17482782-Antineoplastic Agents, pubmed-meshheading:17482782-Chemical Precipitation, pubmed-meshheading:17482782-Crystallization, pubmed-meshheading:17482782-Gastric Emptying, pubmed-meshheading:17482782-Half-Life, pubmed-meshheading:17482782-Humans, pubmed-meshheading:17482782-Intestinal Secretions, pubmed-meshheading:17482782-Intubation, Gastrointestinal, pubmed-meshheading:17482782-Jejunum, pubmed-meshheading:17482782-Male, pubmed-meshheading:17482782-Microscopy, pubmed-meshheading:17482782-Middle Aged, pubmed-meshheading:17482782-Protein Kinase Inhibitors, pubmed-meshheading:17482782-Quinazolines, pubmed-meshheading:17482782-Reference Values, pubmed-meshheading:17482782-Solubility, pubmed-meshheading:17482782-Spectrum Analysis, Raman
pubmed:year
2007
pubmed:articleTitle
Pharmacokinetics of gefitinib in humans: the influence of gastrointestinal factors.
pubmed:affiliation
Department of Pharmacy, Uppsala University, Box 580, 751 23 Uppsala, Sweden.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, Non-U.S. Gov't